Obafemi Awolowo University

This study is testing if adding an affordable malaria drug, artesunate, to the standard leukemia drug imatinib works better than imatinib alone. It aims to help patients, particularly in Nigeria, where access to stronger second-line treatments is limited. The trial will see if th…